Several groundbreaking therapies are now present in the United Kingdom for managing type 2 diabetes . Saxenda, Januvia , and Trulicity represent distinct approaches, with copyright and Jardiance being injectable incretin receptor agonists primarily aimed at fat reduction alongside blood sugar sta